Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DMITRY M YARANOV

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1255607164
CMS profile
2785454
Location
MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$294,587.84

317 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 6 of 7; records 251–300 of 317 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DMITRY M YARANOV

NPI 1255607164 · CMS profile ID 2785454

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 7; records 251–300 of 317 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1255607164?year=2024&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DMITRY M YARANOV, NPI 1255607164, CMS profile ID 2785454. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 317 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1255607164?year=2024&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). DMITRY M YARANOV, NPI 1255607164, CMS profile ID 2785454. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 317 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1255607164?year=2024&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
DMITRY M YARANOV, NPI 1255607164, CMS profile ID 2785454, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 7; records 251–300 of 317 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1255607164?year=2024&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

317 matching records · $294,587.84 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 317 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 317.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
CVRx, Inc. $74.0003/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140963258 CMS
AstraZeneca Pharmaceuticals LP $1,342.5003/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104314658 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $103.6003/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117936187 CMS
CVRx, Inc. $113.4403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140963256 CMS
CVRx, Inc. $29.2503/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140963254 CMS
CVRx, Inc. $88.4803/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124866038 CMS
CVRx, Inc. $38.0103/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140963252 CMS
CVRx, Inc. $741.7103/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124866035 CMS
Merck Sharp & Dohme LLC $540.6002/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745483 CMS
Merck Sharp & Dohme LLC $768.5002/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745803 CMS
Merck Sharp & Dohme LLC $124.7402/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745989 CMS
Merck Sharp & Dohme LLC $149.5302/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141886773 CMS
Abbott Laboratories $16.2202/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124928206 CMS
Merck Sharp & Dohme LLC $4,270.0002/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745325 CMS
Merck Sharp & Dohme LLC $776.2502/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745657 CMS
Merck Sharp & Dohme LLC $850.2002/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745821 CMS
Merck Sharp & Dohme LLC $120.4702/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745981 CMS
AstraZeneca Pharmaceuticals LP $4,300.0002/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104757064 CMS
AstraZeneca Pharmaceuticals LP $4,300.0002/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105552984 CMS
AstraZeneca Pharmaceuticals LP $2,150.0002/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105649948 CMS
Merck Sharp & Dohme LLC $449.6302/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745651 CMS
Merck Sharp & Dohme LLC $517.1902/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745805 CMS
Merck Sharp & Dohme LLC $142.8302/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141885227 CMS
Abbott Laboratories $139.5202/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124928203 CMS
Abbott Laboratories $23.1002/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124928195 CMS
Abbott Laboratories $1.7402/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124928199 CMS
AstraZeneca Pharmaceuticals LP $85.8202/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105399653 CMS
AstraZeneca Pharmaceuticals LP $1,315.5602/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105725371 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.3602/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117936197 CMS
AstraZeneca Pharmaceuticals LP $68.2402/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105540979 CMS
AstraZeneca Pharmaceuticals LP $1,050.0002/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104405533 CMS
PFIZER INC. $29.6702/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131033823 CMS
AstraZeneca Pharmaceuticals LP $88.6302/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104659009 CMS
AstraZeneca Pharmaceuticals LP $2,150.0002/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105890243 CMS
Merck Sharp & Dohme LLC $4,270.0002/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141745485 CMS
Alnylam Pharmaceuticals Inc. $17.7902/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125835641 CMS
Merck Sharp & Dohme LLC $150.0002/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141885233 CMS
AstraZeneca Pharmaceuticals LP $2,150.0002/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104471850 CMS
AstraZeneca Pharmaceuticals LP $2,150.0002/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105288813 CMS
AstraZeneca Pharmaceuticals LP $1,600.0002/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105585998 CMS
AstraZeneca Pharmaceuticals LP $4,300.0002/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105684871 CMS
AstraZeneca Pharmaceuticals LP $4,300.0002/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104285141 CMS
AstraZeneca Pharmaceuticals LP $1,600.0002/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104312938 CMS
AstraZeneca Pharmaceuticals LP $1,050.0002/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104556106 CMS
AstraZeneca Pharmaceuticals LP $27.0002/01/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104664825 CMS
AstraZeneca Pharmaceuticals LP $80.4102/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105617165 CMS
CVRx, Inc. $3,150.0001/31/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1123810589 CMS
AstraZeneca Pharmaceuticals LP $122.9501/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105415915 CMS
AstraZeneca Pharmaceuticals LP $13.7601/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105751695 CMS
AstraZeneca Pharmaceuticals LP $397.0301/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104220827 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,070.26 30
PY2020 $20,989.25 53
PY2021 $10,107.80 90
PY2022 $71,724.90 131
PY2023 $195,417.51 260
PY2024 $294,587.84 317
PY2025 $400,930.23 402

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $109,895.93 21
PY2024 Principal investigator $16,089.50 2
PY2023 Principal investigator $14,912.50 5
PY2021 Principal investigator $3,000.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Abbott Laboratories $21.69 12/19/2025 Non-covered Recipient Entity
MPX Group
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248160976
Principal investigator 1 Abbott Laboratories $21.69 12/17/2025 Non-covered Recipient Entity
MPX Group
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248160876
Principal investigator 1 Abbott Laboratories $50.00 12/10/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248160454
Principal investigator 1 Abbott Laboratories $900.00 12/09/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248160748
Principal investigator 1 Abbott Laboratories $50.00 12/01/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248160452
Principal investigator 1 BrioHealth Solutions, Inc. $14,300.00 11/25/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION
Innovate No dispute reported 06/30/2026 1232714885
Principal investigator 1 Abbott Laboratories $325.00 11/03/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248158960
Principal investigator 1 Abbott Laboratories $11,247.30 11/03/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248158994
Principal investigator 1 Abbott Laboratories $19,888.90 11/03/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248159096
Principal investigator 1 Abbott Laboratories $21.07 10/07/2025 Non-covered Recipient Entity
MPX Group
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248158102
Principal investigator 1 Abbott Laboratories $169.00 08/28/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248156018
Principal investigator 1 Abbott Laboratories $2,090.00 08/28/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248156126
Principal investigator 1 Alexion Pharmaceuticals, Inc. $21,169.60 07/25/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
a phase 3,radomized,double-blind,placebo-controlled,multicenter study to evaluate the efficacy and safety of amyloid depleter ALXN2220 in adult participants wiith transthyretin amyloid cardiomyopathy ATTR CM No dispute reported 06/30/2026 1185546799
Principal investigator 1 Abbott Laboratories $596.00 04/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248150112
Principal investigator 1 Abbott Laboratories $169.00 04/01/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248149576
Principal investigator 1 Abbott Laboratories $12,500.00 03/25/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248147796
Principal investigator 1 Abbott Laboratories $18.98 03/07/2025 Non-covered Recipient Entity
MPX Group
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248147408
Principal investigator 1 Abbott Laboratories $2,764.00 03/07/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248147458
Principal investigator 1 Abbott Laboratories $50.00 02/27/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248148292
Principal investigator 1 Abbott Laboratories $50.00 02/27/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation
NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure No dispute reported 06/30/2026 1248148294
Principal investigator 1 AstraZeneca UK Limited $23,493.70 01/07/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis No dispute reported 06/30/2026 1185546797